Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical ...

Pharmaceutical Industries announced that the companies have entered into a license, development and commercialization agreement for EPYSQLI, Samsung Bioepis’ biosimilar to Soliris in the United States ...

Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH),atypical hemolytic uremic syndrome (aHUS)andgeneralized myasthenia gravis (gMG)in the U ...

South Korean biosimilars developer Samsung Bioepis and Israel’s Teva Pharmaceutical Industries have entered into a license, ...

Amgen’s biosimilar was approved in Europe under the Bekemv brand name last year and competes in the EU with the Samsung Bioepis rival sold as Epysqli. Samsung Bioepis has also filed for approval ...

Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing ...

For more information, or to register for this event, visit The New Era of CDx in Oncology: Adapting Clinical Research Strategy to Evolving Regulations.

Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a public offering price of $3.50 per ...

An image depicting a famous 19th-century painting of Cossacks, with current Ukrainian soldiers standing in for the warriors, has struck a chord as Kyiv battles to assert its identity. By ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

An image depicting a famous 19th-century painting of Cossacks, with current Ukrainian soldiers standing in for the warriors, has struck a chord as Kyiv battles to assert its identity. By ...

The Kremlin has been discussing Donald Trump's claims that a meeting between him and Vladimir Putin is being set up. Meanwhile, Russian elites are concerned with Vladimir Putin's efforts to wage a ...